| scholarly article | Q13442814 |
| P2093 | author name string | Jean Plouët | |
| Coralie Martin | |||
| Jean-Sébastien Silvestre | |||
| Bernard I Levy | |||
| Gérard Tobelem | |||
| Eric Sulpice | |||
| Philippe Foubert | |||
| Boussad Souttou | |||
| Véronique Barateau | |||
| Téni G Ebrahimian | |||
| Carole Leré-Déan | |||
| Jean Olivier Contreres | |||
| Sophie Le Ricousse-Roussanne | |||
| P2860 | cites work | Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 |
| Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells | Q44039853 | ||
| Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. | Q44138748 | ||
| Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization | Q44281968 | ||
| Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling | Q44403591 | ||
| Impaired progenitor cell activity in age-related endothelial dysfunction | Q46464362 | ||
| Eph-ephrin promiscuity is now crystal clear | Q47683124 | ||
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells | Q51345347 | ||
| Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation | Q51667022 | ||
| Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia | Q73395331 | ||
| Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures | Q78570627 | ||
| Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization | Q81685202 | ||
| Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1 | Q81725600 | ||
| Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 | Q24336334 | ||
| Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis | Q24608892 | ||
| Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development | Q28145776 | ||
| Ephrin signaling in vivo: look both ways | Q28296703 | ||
| Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally. | Q30477605 | ||
| Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. | Q30665533 | ||
| Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization | Q30876047 | ||
| Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment | Q31037844 | ||
| Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb | Q33227147 | ||
| Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin | Q33241220 | ||
| The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals | Q33688733 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Eph receptors and ephrin ligands: embryogenesis to tumorigenesis | Q34103639 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| Endothelial progenitor cells: characterization and role in vascular biology | Q35867837 | ||
| Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. | Q35985560 | ||
| Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells | Q36402579 | ||
| Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment | Q39787876 | ||
| Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature | Q40578161 | ||
| Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines | Q40783492 | ||
| Selectins and their ligands: current concepts and controversies. | Q41192497 | ||
| EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. | Q42795950 | ||
| Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis | Q42944903 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1527-1537 | |
| P577 | publication date | 2007-05-17 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells | |
| P478 | volume | 117 |
| Q37743869 | A novel molecule Me6TREN promotes angiogenesis via enhancing endothelial progenitor cell mobilization and recruitment |
| Q36821881 | A review on angiogenesis and its assays |
| Q33754623 | Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia |
| Q53048567 | Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells |
| Q37216602 | Adult progenitor cells in vascular remodeling during atherosclerosis |
| Q42734618 | Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy |
| Q38032602 | Angiogenesis in the infarcted myocardium |
| Q36836510 | Apolipoprotein (a) Impairs Endothelial Progenitor Cell-Mediated Angiogenesis |
| Q42639187 | Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations |
| Q55161029 | CXCR-4 expression by circulating endothelial progenitor cells and SDF-1 serum levels are elevated in septic patients. |
| Q36964223 | Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure |
| Q39320678 | Cigarette Smoke-Induced Failure of Apoptosis Resulting in Enhanced Neoplastic Transformation in Human Bronchial Epithelial Cells |
| Q31122581 | Comparison of Fibronectin and Collagen in Supporting the Isolation and Expansion of Endothelial Progenitor Cells from Human Adult Peripheral Blood |
| Q26781269 | Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease |
| Q34658637 | E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4. |
| Q47694726 | Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q37624581 | Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases |
| Q85010601 | Eph family receptors as therapeutic targets |
| Q34021365 | Eph receptors and ephrins in cancer: bidirectional signalling and beyond |
| Q34681404 | Eph-B4 prevents venous adaptive remodeling in the adult arterial environment |
| Q37971902 | Eph-dependent cell-cell adhesion and segregation in development and cancer. |
| Q37971530 | Eph/ephrin signaling in cell-cell and cell-substrate adhesion. |
| Q36785760 | EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway |
| Q54281857 | EphB2 and EphB3 play an important role in the lymphoid seeding of murine adult thymus. |
| Q47877363 | EphB3 signaling induces cortical endothelial cell death and disrupts the blood-brain barrier after traumatic brain injury |
| Q41917336 | Ephrin-B2-activated peripheral blood mononuclear cells from diabetic patients restore diabetes-induced impairment of postischemic neovascularization |
| Q38055582 | Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis |
| Q41556287 | Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis |
| Q57767255 | HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia |
| Q41964485 | Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions |
| Q37096297 | Homing and engraftment of progenitor cells: a prerequisite for cell therapy |
| Q57789108 | Human decidua basalis mesenchymal stem/stromal cells protect endothelial cell functions from oxidative stress induced by hydrogen peroxide and monocytes |
| Q54338851 | Increased EphB2 expression predicts cholangiocarcinoma metastasis |
| Q35113822 | Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin. |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q34981709 | Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathways |
| Q33317285 | Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus |
| Q37345639 | Possible novel targets for therapeutic angiogenesis |
| Q38048552 | Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases |
| Q39148627 | Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. |
| Q50454679 | Restoring Akt1 activity in outgrowth endothelial cells from South Asian men rescues vascular reparative potential |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q51780800 | Strategies to Enhance the Efficiency of Endothelial Progenitor Cell Therapy by Ephrin B2 Pretreatment and Coadministration with Smooth Muscle Progenitor Cells on Vascular Function During the Wound-Healing Process in Irradiated or Nonirradiated Condi |
| Q52646840 | Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential. |
| Q36402719 | The multifaceted roles of Eph/ephrin signaling in breast cancer |
| Q44799774 | The origin of Kaposi sarcoma |
| Q37734546 | The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development |
| Q38174793 | Therapeutic targeting of EPH receptors and their ligands |
| Q46539901 | Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes. |
| Q57767280 | Thérapie génique et cellulaire dans le traitement des pathologies ischémiques des membres inférieurs |
| Q41895695 | Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension |
| Q52722870 | VCAM-1 expression is upregulated by CD34+/CD133+-stem cells derived from septic patients. |
| Q28237930 | Vasculogenesis: a new piece of the endometriosis puzzle |
| Q89124902 | miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia |
Search more.